Provita Pharmaceutical is working on a project (with funding from the Gates Foundation) to use mosquitoes to help carry vaccines against the West Nile Virus.
The first goal: to genetically engineer mosquitoes so that they can produce and deliver a vaccine via their saliva. It’s a new twist on research being done elsewhere to breed sterile mosquitoes in malaria-infested areas.
And, everyone on the 15-plus person Provita team, from research and development workers to finance officers, is under the age of 18 and still in high school.
(READ the full story from Fast CoExist)